Seoul National University (SNU) / 서울대학교

Corrigendum to ‘Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival’: [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024] (Annals of Oncology (2021) 32(8) (1015–1024), (S0923753421015532), (10.1016/j.annonc.2021.05.353)) (2021) Slamon DJ, Neven P, Chia S, Jerusalem G, De Laurentiis M, Im S, Petrakova K, et al. Journal article, Erratum Is weather chaotic? Coexistence of chaos and order within a generalized lorenz model (2021) Shen BW, Pielke RA, Zeng X, Baik JJ, Faghih-Naini S, Cui J, Atlas R Journal article The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis (2020) Xie J, Liu L, Mladkova N, Li Y, Ren H, Wang W, Cui Z, et al. Journal article Compressively Certifying Quantum Measurements (2020) Gianani , Teo YS, Cimini , Jeong H, Leuchs G, Barbieri M, Sanchez-Soto LL Journal article Pooled analysis of patient (pt)-reported quality of life (QOL) in the MONALEESA (ML)-2,-3, and-7 trials of ribociclib (RIB) plus endocrine therapy (ET) to treat hormone receptore-positive, HER2-negative (HR+/HER2L) advanced breast cancer (ABC) (2020) Fasching P, Bardia A, Nusch A, Jerusalem G, Chan A, El Saghir N, Alba E, et al. Conference contribution Prognostic significance of subtle coronary calcification in patients with zero coronary artery calcium score: From the CONFIRM registry (2020) Han D, Klein E, Friedman J, Gransar H, Achenbach S, Al-Mallah MH, Budoff MJ, et al. Journal article Consumers' consciousness of health-friendly products and services and its association with sociodemographic characteristics and health status: a cross-sectional survey of the South Korean population (2020) Yun YH, Sim JA, Kim Y, Lee S, Kim KN Journal article Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) Liu J, Prager-van der Smissen WJ, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, et al. Journal article Universal Compressive Characterization of Quantum Dynamics (2020) Kim Y, Siah Teo Y, Ahn D, Im DG, Cho YW, Leuchs G, Sanchez-Soto LL, et al. Journal article Quality-adjusted survival with ribociclib plus fulvestrant (R plus F) versus placebo plus fulvestrant (P plus F) in postmenopausal women (PMW) HR+/HER2-advanced breast cancer (ABC) based on the MONALEESA-3 trial (2020) Jerusalem G, Delea T, Martin Jimenez M, De Laurentiis M, Nusch A, Beck JT, Chan A, et al. Conference contribution